Erythropoietin Attenuates Renal Injury in an Experimental Model of Rat Unilateral Ureteral Obstruction via Anti-Inflammatory and Anti-Apoptotic Effects

Journal of Urology

Volumn 181, Issue 3, 2009, Pages 1434-1443

  Chang, Yoon Kyung ^a   Choi, Dae Eun ^b   Na, Ki Ryang ^b   Lee, Sang Ju ^a   Suh, Kwang Sun ^b   Kim, Suk Young ^a   Shin, Young Tai ^b   Lee, Kang Wook ^b  

^a The Catholic University of Korea   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

Author keywords

apoptosis; erythropoietin; inflammation; rats, Sprague Dawley; ureteral obstruction

Indexed keywords

CASPASE 3; CELL PROTEIN; EOSIN; ERYTHROPOIETIN; ERYTHROPOIETIN BETA; FAS ANTIGEN; HEMATOXYLIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KIDNEY INJURY; MALE; MICROSCOPY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; URETER OBSTRUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; INFLAMMATION; KIDNEY DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY; URETERAL OBSTRUCTION;

EID: 59349083513     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.10.105     Document Type: Article

References (19)

1. Ghezzi P., and Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 11 suppl. (2004) S37
2. Maiese K., Li F., and Chong Z.Z. New avenues of exploration for erythropoietin. JAMA 293 (2005) 90
3. Bagnis C., Beaufils H., Jacquiaud C., Adabra Y., Jouanneau C., Le Nahour G., et al. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 16 (2001) 932
4. Vesey D.A., Cheung C., Pat B., Endre Z., Gobe G., and Johnson D.W. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 19 (2004) 348
5. Klahr S., and Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283 (2002) F861
6. Truong L.D., Choi Y.J., Tsao C.C., Ayala G., Sheikh-Hamad D., Nassar G., et al. Renal cell apoptosis in chronic obstructive uropathy: the roles of caspases. Kidney Int 60 (2001) 924
7. Park S.H., Choi M.J., Song I.K., Choi S.Y., Nam J.O., Kim C.D., et al. Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition. J Am Soc Nephrol 18 (2007) 1497
8. Kitamura H., Isaka Y., Takabatake Y., Imamura R., Suzuki C., Takahara S., et al. Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model. Nephrol Dial Transplant 23 (2008) 1521
9. Yang C.W., Li C., Jung J.Y., Shin S.J., Choi B.S., Lim S.W., et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 17 (2003) 1754
10. Johnson D.W., Pat B., Vesey D.A., Guan Z., Endre Z., and Gobe G.C. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int 69 (2006) 1806
11. Misseri R., Meldrum D.R., Dinarello C.A., Dagher P., Hile K.L., Rink R.C., et al. TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol 288 (2005) F406
12. Crisman J.M., Richards L.L., Valach D.P., Franzoni D.F., and Diamond J.R. Chemokine expression in the obstructed kidney. Exp Nephrol 9 (2001) 241
13. Villa P., Bigini P., Mennini T., Agnello D., Laragione T., Cagnotto A., et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198 (2003) 97
14. Kang D.H., Park E.Y., Yu E.S., Lee Y.S., and Yoon K.I. Renoprotective effect of erythropoietin (EPO): possibly via an amelioration of renal hypoxia with stimulation of angiogenesis in the kidney. Kidney Int 67 (2005) 1683
15. Isaka Y., Tsujie M., Ando Y., Nakamura H., Kaneda Y., Imai E., et al. Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 58 (2000) 1885
16. Seseke F., Thelen P., Heuser M., Zoller G., and Ringert R.H. Impaired nephrogenesis in rats with congenital obstructive uropathy. J Urol 165 (2001) 2289
17. Choi Y.J., Baranowska-Daca E., Nguyen V., Koji T., Ballantyne C.M., Sheikh-Hamad D., et al. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules. Kidney Int 58 (2000) 1481
18. Lama G., Ferraraccio F., Iaccarino F., Luongo I., Marte A., Rambaldi P.F., et al. Pelviureteral junction obstruction: correlation of renal cell apoptosis and differential renal function. J Urol 169 (2003) 2335
19. Schmidt E.K., and Fichelson SandFeller S.M. PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors. BMC Biol 2 (2004) 7